Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng Tong

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
Mycoses|October 22, 2020
Aetiology of superficial fungal infections of the foot in urban outpatients in mainland China: A multicentre, prospective case studyJin Yu, Wei-Da Liu, Zhong-Sheng Tong, et al.
Ageing Research Reviews|November 16, 2023
Global, regional, and national prevalence of hearing loss from 1990 to 2019: A trend and health inequality analyses based on the Global Burden of Disease Study 2019Chuan-Ya Jiang, Ke Han, Fan Yang, et al.
Ageing Research Reviews|June 11, 2025
Trends and Mechanisms of Alzheimer's Disease and Hearing Impairment: A 20-Year PerspectiveFen-Fen Li, Jian-Peng Wang, Wen-Jie Zhang, et al.
Autoimmunity Reviews|November 9, 2024
Global trend analysis, mechanistic insights and future directions of autoimmune ear diseases: Based on comprehensive findings over the past 20 yearsYu-Chen Liu, Yi-Pin Yang, Yan-Xun Han, et al.
The Lancet. Oncology|March 22, 2015
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trialXi-Chun Hu, Jian Zhang, Bing-He Xu, et al.
Therapeutic Advances in Medical Oncology|November 5, 2020
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer: the multinational randomized phase III studyQing Yuan Zhang, Tao Sun, Yong Mei Yin, et al.
Annals of Translational Medicine|August 29, 2022
Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in ChinaHuan Yang, Qu-Chang Ouyang, Min Yan, et al.
Frontiers in Oncology|February 10, 2023
Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective studyJin-Hu Fan, Su Zhang, Huan Yang, et al.
Journal of Oncology|September 27, 2021
Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from ChinaYi-Qun Han, Zong-Bi Yi, Pei Yu, et al.
International Journal of Cancer|July 24, 2020
Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological studyZong-Bi Yi, Pei Yu, Su Zhang, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Mycoses|October 22, 2020
Aetiology of superficial fungal infections of the foot in urban outpatients in mainland China: A multicentre, prospective case studyJin Yu, Wei-Da Liu, Zhong-Sheng Tong, et al.
Ageing Research Reviews|November 16, 2023
Global, regional, and national prevalence of hearing loss from 1990 to 2019: A trend and health inequality analyses based on the Global Burden of Disease Study 2019Chuan-Ya Jiang, Ke Han, Fan Yang, et al.
Ageing Research Reviews|June 11, 2025
Trends and Mechanisms of Alzheimer's Disease and Hearing Impairment: A 20-Year PerspectiveFen-Fen Li, Jian-Peng Wang, Wen-Jie Zhang, et al.
Autoimmunity Reviews|November 9, 2024
Global trend analysis, mechanistic insights and future directions of autoimmune ear diseases: Based on comprehensive findings over the past 20 yearsYu-Chen Liu, Yi-Pin Yang, Yan-Xun Han, et al.
The Lancet. Oncology|March 22, 2015
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trialXi-Chun Hu, Jian Zhang, Bing-He Xu, et al.
Therapeutic Advances in Medical Oncology|November 5, 2020
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer: the multinational randomized phase III studyQing Yuan Zhang, Tao Sun, Yong Mei Yin, et al.
Annals of Translational Medicine|August 29, 2022
Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in ChinaHuan Yang, Qu-Chang Ouyang, Min Yan, et al.
Frontiers in Oncology|February 10, 2023
Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective studyJin-Hu Fan, Su Zhang, Huan Yang, et al.
Journal of Oncology|September 27, 2021
Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from ChinaYi-Qun Han, Zong-Bi Yi, Pei Yu, et al.
International Journal of Cancer|July 24, 2020
Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological studyZong-Bi Yi, Pei Yu, Su Zhang, et al.
Pageof 19